These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7250759)

  • 1. A comparison of two radioimmunoassay methods for the detection of carcinoembryonic antigen in patients with ovarian or cervical cancer.
    Magon H; Daunter B; Khoo SK; Mackay EV
    Gynecol Oncol; 1981 Jun; 11(3):340-7. PubMed ID: 7250759
    [No Abstract]   [Full Text] [Related]  

  • 2. A multiparametric approach to tumor markers detectable in serum in patients with carcinoma of the ovary or uterine cervix.
    Sarjadi S; Daunter B; Mackay E; Magon H; Khoo SK
    Gynecol Oncol; 1980 Oct; 10(2):113-24. PubMed ID: 6161862
    [No Abstract]   [Full Text] [Related]  

  • 3. Carcinoembryonic antigen in gynecologic patients. I. Correlation of plasma levels and tissue localization.
    Puri S; Mesa-Tejada R; Husami N; Bennett S; Richart RM; Fenogolio CM
    Gynecol Oncol; 1977 Dec; 5(4):331-7. PubMed ID: 590854
    [No Abstract]   [Full Text] [Related]  

  • 4. [CEA monitoring of gynecologic tumor patients using a simplified CEA-radioimmunoassay].
    Hörst M; Wiest W
    Fortschr Med; 1982 Mar; 100(11):482-3. PubMed ID: 7076078
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical significance of plasma lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA) in gynaecologic cancer patients.
    Tredese F; Maggino T; Salvagno L; Marchesoni D; Chizzolini M; Pattaro RF
    Eur J Gynaecol Oncol; 1985; 6(2):136-8. PubMed ID: 4029198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen by radioimmunoassay in the detection of recurrence during long-term followup of female genital cancer.
    Khoo SK; Mackay EV
    Cancer; 1974 Sep; 34(3):542-8. PubMed ID: 4850874
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical markers in gynaecological cancer.
    Farrell RJ
    Ir Med J; 1980 Aug; 73(8):285-6. PubMed ID: 6161106
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical application of serum CEA and ferritin levels in cervical cancer patients (author's transl)].
    Ito H; Kubo A; Hashimoto S; Tsutsui F; Kurihara S
    Kaku Igaku; 1980 Feb; 17(1):1-7. PubMed ID: 7382172
    [No Abstract]   [Full Text] [Related]  

  • 9. Carcinoembryonic antigen and beta 2-microglobulin as serum tumor markers in women with genital cancer.
    Khoo SK; Daunter B; Mackay E
    Int J Gynaecol Obstet; 1979; 16(5):388-93. PubMed ID: 86469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monitoring the course of malignant neoplasms of the genital organs in women by means of determination of blood serum level of fucose, sialic acid, CEA and AFP].
    Simm S; Markowska J; Tomaszkiewicz T; Herwichowska K; Breborowicz J
    Ginekol Pol; 1979 Dec; 50(12):1029-36. PubMed ID: 94024
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinoembryonic antigen in gynecologic patients. II. Immunohistological expression.
    Fenoglio CM; Crum CP; Pascal RR; Richart RM
    Diagn Gynecol Obstet; 1981; 3(4):291-9. PubMed ID: 7338157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial determination of marker substances in ovarian cancer.
    Stanhope CR; Smith JP; Britton JC; Crosley PK
    Gynecol Oncol; 1979 Dec; 8(3):284-7. PubMed ID: 92437
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppressive acidic protein in patients with gynecologic cancer.
    Sawada M; Okudaira Y; Matsui Y; Shimizu Y
    Cancer; 1984 Aug; 54(4):652-6. PubMed ID: 6744202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of carcinoembryonic antigen (CEA) methodologies.
    Fleisher M; Besenfelder E; Oettgen HF; Schwartz MK
    Ann Clin Lab Sci; 1974; 4(5):357-62. PubMed ID: 4851106
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical significance of different serum tumor markers in gynecological malignancies.
    Paulick R; Caffier H; Horner G; Lang K; Filbry E
    Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of 2 direct methods for the radioimmunologic determination of carcinoembryonic antigen].
    Bali JP; Fournajoux J; Sebah H; Balmès ; Marignan R
    Biol Gastroenterol (Paris); 1973; 6(4):297-306. PubMed ID: 4215467
    [No Abstract]   [Full Text] [Related]  

  • 17. Radioimmunodetection of cancer using antibodies to alpha-fetoprotein and carcinoembryonic antigen.
    Ishii N; Nakata K; Muro T; Furukawa R; Kono K; Kusumoto Y; Munehisa T; Koji T; Nagataki S; Nishi S
    Ann N Y Acad Sci; 1983; 417():270-6. PubMed ID: 6200035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)].
    Anger H; Gleissenberger U
    Geburtshilfe Frauenheilkd; 1977 Jul; 37(7):604-8. PubMed ID: 885332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the occurrence of CEA in the blood of women with cervical neoplasms].
    Kotarski J
    Ginekol Pol; 1986 Apr; 57(4):300-3. PubMed ID: 3758768
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinoembryonic antigen (CEA): comparison of the Farr and solid-phase methods for detection of CEA.
    McPherson TA; Band PR; Grace M; Hyde HA; Patwardhan VC
    Int J Cancer; 1973 Jul; 12(1):42-54. PubMed ID: 4597862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.